Hey all. I'm one of those lurkers on this board that hardly
Hey all. I'm one of those lurkers on this board that hardly ever posts but always keeps up with this board. Wanted to share something. My mom is a nurse manager at a Los Angeles County hospital affiliated with UCLA Medical Center. Because of this I've been telling my mom to reach out to Dr. Otto Yang or do whatever she can to try to get leronlimab at her hospital. We've both been invested in Cytodyn since 2016. Today she told me that she just so happened to walk into a room where there was an ongoing zoom meeting and she heard two doctors discussing leronlimab and the prospects of bringing it to the hospital. I was glad to hear this and I told her she's got to go bug these doctors to get them to bring it in! So the good news is that awareness of the drug is spreading. I'll keep you guys posted if there's any update.
While I'm here, I'll chime in my 2 cents. My first post on this board was to discuss what I thought was a big issue for this company - that they did nothing to spread awareness about the fact that the company even existed. Covid has been a blessing in this regard and I'm so glad everytime I hear that a new hospital is being added as a trial site. I have no knowledge about the medical industry but the way I see it is the fact that all these new hospitals/doctors now know about leronlimab, when they otherwise would not have if it weren't for covid, these hospitals/doctors can be used to help fill our cancer trials and other trials. If I was Nader I'd maintain all these new connections with these hospitals/doctors and when the times right have them help enroll our basket cancer, long hauler and other trials. How can a doctor say no to this drug once they're familiar with it?
GLTA
27
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Eyes on Photronics: A Legal Quake Anytime you hear a stock price nosedive like a kamikaze just blew up its own runway, it ought to set off every investor's alarms. And if you’re tied into Photronics (NASDAQ:PLAB), buddy, it's time to catch up on what's driving this train off the rails. With a class period stretching from December 2025 through May 2026, the dish is a...
Continue Reading
Lyntris and KSAT: A Technological Feat in Space Connectivity Well, if it ain't Lyntris back in the headlines again, pushing the envelope on space connectivity. If you're keeping tabs on the space tech space, there's a cracker of a development brewing. Lyntris Inc. (NYSE: LYNX) just checked off a crucial box in their playbook—the Critical Design Review, or CDR for those...
Continue Reading
Jim Morey: Catalyst for Pickleman's Ambitious Dreams You ever heard of a sandwich joint ready to take on the big leagues? Because that's just what Pickleman's Gourmet Café is banking on with their latest move—tapping none other than Jim Morey for their executive advisory board. And let me tell ya, this ain't some run-of-the-mill hire. We're talking about a guy who's...
Continue Reading
Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...
Continue Reading
Data Accuracy in Healthcare: A Persistent Problem Just when you think data's about numbers and cold, hard facts, healthcare jolts you awake. Perspecta's fresh insights onto provider data accuracy aren't just a snooze fest of statistics but a genuine wake-up call. This report peels open a can of worms some might prefer to ignore. With only half of provider data accurate,...
Continue Reading
Changing the Game in Power Generation In the ever-shifting landscape of power generation, having a seasoned player at the helm can be the difference between stagnation and growth. FirstEnergy Corp. (NYSE:FE) has tapped Jon Dormo as its Vice President of Generation Project Development. The mission? Overhaul and expand projects to meet the increasing demands for...
Continue Reading
Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...
Continue Reading
Piling Up the Accolades: McCann Systems Does It Again You know, getting industry awards can sometimes feel like counting beans, but when a company's snagging them year after year, that’s worth noting. McCann Systems is strutting its stuff with two Commercial Integrator Awards in 2026, cementing their reputation not just here in New Jersey, but across the AV industry....
Continue Reading
When Money Talks Fast: Market Funds Smash Records Picture this: money market funds have surged to an eye-watering $7.98 trillion. That's a lot of zeros, folks. And it's not just the usual humdrum growth; we're talking a hefty $44.75 billion increase in just one week, thanks to a cocktail of government funds and prime fund muscle, as the Investment Company Institute (ICI)...
Continue Reading
When weight loss turns hairy, it's not just an old wives' tale. We have some solid evidence from those eggheads at NYU Langone Health, who unearthed this hairy connection between popular weight loss drugs and the glinting domes of the genetically predisposed. Understanding the Hair-Drug Connection The name Ozempic might sound familiar, and not just because it's been...
Continue Reading
Top 5 Most Recently Viewed Articles
Introducing the ELEVATE Partner Program from Cynomi Cynomi has launched an innovative partner program called ELEVATE aimed at enhancing the growth of Managed Service Providers (MSPs) and Managed Security Service Providers (MSSPs). Designed to provide scalable cybersecurity solutions, this initiative is set to transform how partners deliver critical cybersecurity and...
Continue Reading
Strategic Partnership Between Tri-anim and Telesair Tri-anim Health Services, a leader in specialty distribution for respiratory and critical care medical products, has officially teamed up with Telesair, Inc., a dynamic player in the medical technology space. This collaboration introduces a distribution agreement that empowers Tri-anim to exclusively distribute...
Continue Reading
Understanding Recent Trends in US Indexes Recent fluctuations in the stock market have captured the attention of traders and investors alike. The Emini S&P and Nasdaq indexes have faced notable declines, leading to concerns about future movements. In the latest trading sessions, the Emini S&P broke through significant support levels, hitting new lows. Emini S&P March...
Continue Reading
Empowered Investors Take Action Against Digimarc Corporation In recent news, investors are presented with a significant opportunity to engage in a class action lawsuit against Digimarc Corporation, a company specializing in digital identification and data management technology. This class action, initiated by a recognized national shareholder rights litigation firm, seeks...
Continue Reading
Fairway Home Mortgage's Generous Contribution Fairway Home Mortgage, a prominent mortgage bank with a significant presence in the industry, has made headlines by donating $1,000,000 to support relief efforts following severe flooding incidents that have recently impacted communities, particularly in Texas. This commendable effort aims not only to provide aid to those in...
Continue Reading